These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37936510)

  • 1. Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.
    Santana CR; de Oliveira MGG; Camargo MS; Moreira PMB; de Castro PR; Aguiar EC; Mistro S
    Int J Pharm Pract; 2024 Feb; 32(1):46-51. PubMed ID: 37936510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
    Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
    BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a collaborative diabetes screening campaign between community pharmacies and general practitioners.
    Murteira R; Cary M; Galante H; Romano S; Guerreiro JP; Rodrigues AT
    Prim Care Diabetes; 2023 Aug; 17(4):314-320. PubMed ID: 37156696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocol.
    Gourlay A; Sutherland C; Radley A
    BMJ Open; 2023 May; 13(5):e072882. PubMed ID: 37173112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    PLoS One; 2018; 13(2):e0191316. PubMed ID: 29474501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of point-of-care HbA1c testing in pregnant women.
    Culliney K; McCowan LME; Okesene-Gafa K; Murphy R; Rowan J; Taylor RS; Mckinlay CJD;
    Aust N Z J Obstet Gynaecol; 2018 Dec; 58(6):643-647. PubMed ID: 29468638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using glycated haemoglobin testing to simplify diabetes screening in remote Aboriginal Australian health care settings.
    Marley JV; Oh MS; Hadgraft NT; Singleton SL; Isaacs K; Atkinson DN
    Med J Aust; 2015 Jul; 203(1):28-32. PubMed ID: 26126564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study.
    Kumar PR; Bhansali A; Ravikiran M; Bhansali S; Dutta P; Thakur JS; Sachdeva N; Bhadada SK; Walia R
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2832-5. PubMed ID: 20371663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of glycated haemoglobin and fasting blood glucose in the diagnosis of diabetes mellitus and pre-diabetes in a cohort of obese patients.
    Chan DML; Murphy M
    J R Nav Med Serv; 2017; 103(1):39-43. PubMed ID: 30088739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated haemoglobin in diagnosis of diabetes mellitus and pre-diabetes among middle-aged and elderly population: Shanghai Changfeng study.
    Ma H; Gao X; Lin HD; Hu Y; Li XM; Gao J; Zhao NQ
    Biomed Environ Sci; 2013 Mar; 26(3):155-62. PubMed ID: 23425797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes risk assessments and HbA1c-measurements in community pharmacies.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    Int J Pharm Pract; 2023 Sep; 31(5):512-519. PubMed ID: 37527496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Haemoglobin A1c in Screening Obese Children and Adolescents for Glucose Intolerance and Type 2 Diabetes.
    Galhardo J; Shield J
    Acta Med Port; 2015; 28(3):307-15. PubMed ID: 26421782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy.
    Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Mc Namara KP
    Diabetes Res Clin Pract; 2023 Mar; 197():110566. PubMed ID: 36738834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of haemoglobin A1c based dysglycaemia among adult community dwellers in selected states in Nigeria: a descriptive cross-sectional study.
    Ajayi IO; Balogun WO; Olopade OB; Ajani GO; Soyoye DO; Bolarinwa OA; Olamoyegun MA; Alatishe-Muhammad BW; Odeniyi IA; Odukoya O; Fasanmade OA; Diyaolu FP; Otrofanowei E; Akase I; Agabi PO; Adejimi A; Ajetunmobi OA; Durowade KA; Gabriel-Alayode EO; Ibrahim AO; Ezekpo OO; Elegbede TO; Lamidi AO; Owolabi FA; Yusuf AO; Adetunji TA; Ogunmodede AJ; Ameen AH; Biliaminu AS; Nasiru S
    Front Endocrinol (Lausanne); 2023; 14():1192491. PubMed ID: 37547317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacy-based A1c screening: a Canadian model for diabetes care.
    Papastergiou J; Folkins C; Li W
    Int J Pharm Pract; 2016 May; 24(3):189-95. PubMed ID: 26670476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ADA HbA1c criteria in the diagnosis of pre-diabetes and diabetes in a population of Chinese adolescents and young adults at high risk for diabetes: a cross-sectional study.
    Li G; Han L; Wang Y; Zhao Y; Li Y; Fu J; Li M; Gao S; Willi SM
    BMJ Open; 2018 Aug; 8(8):e020665. PubMed ID: 30093511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA
    Kenealy T; Herd G; Musaad S; Wells S
    Prim Care Diabetes; 2019 Apr; 13(2):170-175. PubMed ID: 30545795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of mismatches in HbA
    Gonzalez A; Deng Y; Lane AN; Benkeser D; Cui X; Staimez LR; Ford CN; Khan FN; Markley Webster SC; Leong A; Wilson PWF; Phillips LS; Rhee MK
    Diabet Med; 2020 Apr; 37(4):689-696. PubMed ID: 31721287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care HbA1c screening predicts diabetic status of dental patients.
    Franck SD; Stolberg RL; Bilich LA; Payne LE
    J Dent Hyg; 2014 Feb; 88(1):42-52. PubMed ID: 24563052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.